You are here

XPhyto Therapeutics Corp.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
XPHY
CSE Index: 
Currency: 

XPhyto Therapeutics Corp. (“XPhyto”) is a diversified bioscience company with strategic assets and investments in the field of rapid pathogen screening systems and next generation drug delivery, as well as medical cannabis opportunities focused on emerging European markets. Through its 100% owned subsidiaries and exclusive development and commercialization agreements, XPhyto is pursuing clinical programs for the transdermal and dissolvable oral delivery of conventional and cannabis based therapeutics for neurological applications, as well as rapid dissolvable oral biosensor and lateral flow assay-based screening tests for dental health applications and high-risk pandemic threats such as COVID-19, H1N1 (swine flu) and H5N1 (avian flu).

You are here

XPhyto Therapeutics Corp. (XPHY)

SEDAR Information

Company Info

Address
Suite 270 - 1820 Fir Street
Vancouver, BC V6J 3B1
Canada
Phone
780-818-6422
Email
info@xphyto.com
Listing date
Wednesday, July 31, 2019
Transfer Agent
Computershare Investor Services Inc.

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
60,617,445
Reserved for Issuance: 
21,847,557

Bulletins

Advertisement

Publicité

Latest CSE News

Upcoming Events

2020-10-20-TT-Website.png

Tech Tuesdays

Tuesday, October 20, 2020 -
4:15pm to 5:00pm
2020-10-21-Cannabis-and-Tech_Website.jpg

Cannabis + Technology

Wednesday, October 21, 2020 - 9:30am to Thursday, October 22, 2020 - 7:00pm
2020-09-30-The-Psychedelics-Renaissance_Website_1.png

The Psychedelics Renaissance

Wednesday, October 21, 2020 -
1:00pm to 3:00pm